The Cancer Cell Line Project – Patients contributing their tissue samples during a biopsy or surgery are directly impacting LMS Research in a big way – see the details of this program by visiting: leiomyosarcoma.info
RCRF Cancer Cell Line project partnership with the NLMSF established to include leiomyosarcoma ANNOUNCED APRIL 9, 2017:
THE TAPUR STUDY (www.tapur.org):
The Targeted Agent and Profiling Utilization Registry (TAPUR) study is a clinical trial for people with advanced cancer whose cancer is no longer responding to standard treatment or for whom there is no standard treatment available.
A patient’s cancer must also have a potentially actionable genomic variant already identified through a genomic test –talk to your oncologist about this for more information about participating in a TAPUR study and the genomic testing step.
The TAPUR study aims to:
- learn whether approved drugs might work against different cancers
- find out how genomic or molecular tests are used to care for people with advanced cancer
- use the study results to help inform future studies and aid in the care of people with cancer
- provide patients with access to therapies which may benefit them
The TAPUR STUDY website will have information about the eligibility of the study; latest news and study announcements, the list of drugs available in the study, and a current listing of study sites in the country.